Malaria
Medication for Sub-Sahara
08/03/07 13:40 Filed in:
Morocco
Articles
In a recent press release from Paris,
Morocco has stated that it is helping its
sister countries with a new “simplified and
low-cost” treatment for malaria for those
who suffer from the disease in sub-Saharan
African countries. The new treatment, from
the pharmaceutical group of Sanofi-Aventis
has been dubbed ASAQ and will drastically
help countries where malaria kills nearly
one million people per year.
The new treatment, which will be released
over the next year, will cost twice as much
for adults as for children, because they
need twice the dose of effective treatment.
The total cost will be USD .50 for children
and USD 1.00 for adults – the cheapest
treatment ever released.
Robert Sebagg, who spoke at the news
conference, said that the new treatment is
a partnership between Sanofi-Aventis and an
initiative known as called DNDi (Initiative
pour des médicaments en faveur des maladies
négligées). The factory that will produce
the malaria treatment, located in
Casablanca, will produce millions of doses
per year that will be taken and marketed in
the sub-Saharan African countries most in
need. Many hope that the un-patented
production and sales will keep the cure
affordable for those who once couldn’t
afford the medication.
Brought to you by:
Morocco News
at Journey Beyond Travel
Source: Maghreb Arabe Presse
Tags:
morocco morocco news
morocco travel
maghreb